Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: A model for reactivation from latency

Journal of Virology

Volumn 75, Issue 10, 2001, Pages 4814-4822

  Hummel, M ^a   Zhang, Z ^a   Yan, S ^a   Deplaen, I ^a   Golia, P ^a   Varghese, T ^a   Thomas, G ^a   Abecassis, M I ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; GENE INDUCTION; IMMEDIATE EARLY GENE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS REACTIVATION;

ANIMALS; CYTOKINES; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; GENES, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MUROMEGALOVIRUS; NF-KAPPA B; TRANS-ACTIVATORS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0035032244     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.10.4814-4822.2001     Document Type: Article

References (81)

1. Detection of murine cytomegalovirus (MCMV) DNA in skin using the polymerase chain reaction (PCR)
2. The NF-kB and IkB proteins: New discoveries and insights
3. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
4. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice
5. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction
6. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation
7. Polyclonal antilymphocyte sera induce immune activation in human renal allograft recipients
8. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
9. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
10. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases
11. Passive transfer of cytomegalovirus by cardiac and renal organ transplants in a rat model
12. The transfer of cytomegalovirus infection in rats by latently infected renal allografts, and the role of various immunosuppressive regimens in virus reactivation
13. Transmission and activation of cytomegalovirus with blood transfusion: A mouse model
14. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts
15. Cytokine gene transcription in vascularised organ grafts: Analysis using semiquantitative polymerase chain reaction
16. Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin
17. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor
18. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues
19. Cytomegalovirus reactivation and tumour necrosis factor
20. A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus
21. Enhancement of murine cytomegalovirus infection during graft-vs.-host reaction
22. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo
23. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor
24. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
25. Serum cytokines in human heart transplant recipients. Is there a relationship to rejection?
26. Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression
27. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells
28. A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1
29. Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model
30. Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice
31. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3
32. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements
33. Expression des genes des cytokines et des genes associés a l'interferon chez l'embryon de la souris
34. Cellular localization of latent murine cytomegalovirus
35. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals
36. Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs
37. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs
38. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence
39. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40
40. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
41. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements
42. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
43. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1
44. NF-kappa B is activated during acute inflammation in vivo in association with elevated endothelial cell adhesion molecule gene expression and leukocyte recruitment
45. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1
46. CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: Association with survival and graft-versus-host disease
47. Activation of latent murine cytomegalovirus infection: Cocultivation, cell transfer, and the effect of immunosuppression
48. Reactivation of murine cytomegalovirus by cyclophosphamide
49. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors
50. Cytomegaloviruses and their replication
51. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients
52. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
53. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection
54. Stimulation of the human cytomegalovirus IE enhancer/ promoter in HL-60 cells by TNF alpha is mediated via induction of NF-kB
55. Human cytomegalovirus infection in transplant recipients: Role of TNF-alpha for reactivation and replication of human cytomegalovirus
56. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection
57. Constructing polycompetitor cDNAs for quantitative PCR
58. Herpes simplex viruses and their replication
59. Impact of cytomegalovirus infection on organ transplant recipients
60. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation
61. Aging and reactivation of latent murine cytomegalovirus
62. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
63. Quantitative analysis of latent human cytomegalovirus
64. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors
65. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
66. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function
67. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells
68. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoterregulatory sequence and by virus-specific trans-acting components
69. Differential activation of heat shock and nuclear factor kappaB transcription factors in postischemic reperfused rat liver
70. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells
71. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers
72. Promoter-regulatory region of the major immediate early gene of human cytomegalovirus
73. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase
74. Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection
75. Herpes simplex viruses
76. Reactivation of latent cytomegalovirus in allografts: Comparison of lung graft and kidney graft in rats
77. Expression of a murine cytomegalovirus early-late protein in "latently" infected mice
78. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice
79. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Spl and NF-κB during infection
80. Improved techniques for kidney transplantation in mice
81. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation